Skip to main content

Radiographic Assessment for Liver Tumors

  • Chapter
  • First Online:
Primary and Metastatic Liver Tumors

Abstract

Imaging plays a pivotal role in management of benign and malignant liver tumors. A wide range of modalities including both conventional and modern, state-of-the-art imaging techniques provide invaluable information for better management of patients with suspected hepatic tumors. Besides the technique itself, knowledge of characteristics of a particular lesion and appropriate employment of this information to prescribe optimal management are critical. In this chapter, we discuss imaging characteristics of more frequently encountered benign and malignant hepatic tumors.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Edrei Y, Gross E, Corchia N, Tsarfaty G, Galun E, Pappo O, et al. Vascular profile characterization of liver tumors by magnetic resonance imaging using hemodynamic response imaging in mice. Neoplasia. 2011;13(3):244–53.

    Article  Google Scholar 

  2. Llovet JM, Bruix J. Novel advancements in the management of hepatocellular carcinoma in 2008. J Hepatol. 2008;48(Suppl 1):S20–37. https://doi.org/10.1016/j.jhep.2008.01.022.

    Article  CAS  PubMed  Google Scholar 

  3. Choi BY, Nguyen MH. The diagnosis and management of benign hepatic tumors. J Clin Gastroenterol. 2005;39(5):401–12.

    Article  Google Scholar 

  4. Margonis GA, Ejaz A, Spolverato G, Rastegar N, Anders R, Kamel IR, et al. Benign solid tumors of the liver: management in the modern era. J Gastrointest Surg. 2015;19(6):1157–68. https://doi.org/10.1007/s11605-014-2723-x.

    Article  PubMed  Google Scholar 

  5. van Sonnenberg E, Wroblicka JT, D'Agostino HB, Mathieson JR, Casola G, O’Laoide R, et al. Symptomatic hepatic cysts: percutaneous drainage and sclerosis. Radiology. 1994;190(2):387–92. https://doi.org/10.1148/radiology.190.2.8284385.

    Article  Google Scholar 

  6. Mathieu D, Vilgrain V, Mahfouz AE, Anglade MC, Vullierme MP, Denys A. Benign liver tumors. Magn Reson Imaging Clin N Am. 1997;5(2):255–88.

    CAS  PubMed  Google Scholar 

  7. Klotz T, Montoriol PF, Da Ines D, Petitcolin V, Joubert-Zakeyh J, Garcier JM. Hepatic haemangioma: common and uncommon imaging features. Diagn Interv Imaging. 2013;94(9):849–59. https://doi.org/10.1016/j.diii.2013.04.008.

    Article  CAS  PubMed  Google Scholar 

  8. Vilgrain V, Boulos L, Vullierme MP, Denys A, Terris B, Menu Y. Imaging of atypical hemangiomas of the liver with pathologic correlation. Radiographics. 2000;20(2):379–97. https://doi.org/10.1148/radiographics.20.2.g00mc01379.

    Article  CAS  PubMed  Google Scholar 

  9. Lencioni R, Cioni D, Bartolozzi C, Baert AL. Focal liver lesions: detection, characterization, ablation. Milan: Springer; 2005.

    Book  Google Scholar 

  10. Yu JS, Kim MJ, Kim KW, Chang JC, Jo BJ, Kim TH, et al. Hepatic cavernous hemangioma: sonographic patterns and speed of contrast enhancement on multiphase dynamic MR imaging. AJR Am J Roentgenol. 1998;171(4):1021–5. https://doi.org/10.2214/ajr.171.4.9762989.

    Article  CAS  PubMed  Google Scholar 

  11. Tanaka S, Kitamura T, Fujita M, Nakanishi K, Okuda S. Color Doppler flow imaging of liver tumors. AJR Am J Roentgenol. 1990;154(3):509–14. https://doi.org/10.2214/ajr.154.3.2154912.

    Article  CAS  PubMed  Google Scholar 

  12. Perkins AB, Imam K, Smith WJ, Cronan JJ. Color and power Doppler sonography of liver hemangiomas: a dream unfulfilled? J Clin Ultrasound. 2000;28(4):159–65.

    Article  CAS  Google Scholar 

  13. Nino-Murcia M, Ralls PW, Jeffrey RB Jr, Johnson M. Color flow Doppler characterization of focal hepatic lesions. AJR Am J Roentgenol. 1992;159(6):1195–7. https://doi.org/10.2214/ajr.159.6.1332456.

    Article  CAS  PubMed  Google Scholar 

  14. Yamashita Y, Ogata I, Urata J, Takahashi M. Cavernous hemangioma of the liver: pathologic correlation with dynamic CT findings. Radiology. 1997;203(1):121–5. https://doi.org/10.1148/radiology.203.1.9122378.

    Article  CAS  PubMed  Google Scholar 

  15. Hanafusa K, Ohashi I, Himeno Y, Suzuki S, Shibuya H. Hepatic hemangioma: findings with two-phase CT. Radiology. 1995;196(2):465–9. https://doi.org/10.1148/radiology.196.2.7617862.

    Article  CAS  PubMed  Google Scholar 

  16. Kim KW, Kim TK, Han JK, Kim AY, Lee HJ, Choi BI. Hepatic hemangiomas with arterioportal shunt: findings at two-phase CT. Radiology. 2001;219(3):707–11. https://doi.org/10.1148/radiology.219.3.r01ma05707.

    Article  CAS  PubMed  Google Scholar 

  17. Naganuma H, Ishida H, Konno K, Hamashima Y, Komatsuda T, Ishida J, et al. Hepatic hemangioma with arterioportal shunts. Abdom Imaging. 1999;24(1):42–6.

    Article  CAS  Google Scholar 

  18. Kim T, Federle MP, Baron RL, Peterson MS, Kawamori Y. Discrimination of small hepatic hemangiomas from hypervascular malignant tumors smaller than 3 cm with three-phase helical CT. Radiology. 2001;219(3):699–706. https://doi.org/10.1148/radiology.219.3.r01jn45699.

    Article  CAS  PubMed  Google Scholar 

  19. Caseiro-Alves F, Brito J, Araujo AE, Belo-Soares P, Rodrigues H, Cipriano A, et al. Liver haemangioma: common and uncommon findings and how to improve the differential diagnosis. Eur Radiol. 2007;17(6):1544–54. https://doi.org/10.1007/s00330-006-0503-z.

    Article  PubMed  Google Scholar 

  20. Shim KS, Suh JM, Yang YS, Kim JG, Kang SJ, Jeon JS, et al. Sclerosis of hepatic cavernous hemangioma: CT findings and pathologic correlation. J Korean Med Sci. 1995;10(4):294–7. https://doi.org/10.3346/jkms.1995.10.4.294.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Semelka RC, Brown ED, Ascher SM, Patt RH, Bagley AS, Li W, et al. Hepatic hemangiomas: a multi-institutional study of appearance on T2-weighted and serial gadolinium-enhanced gradient-echo MR images. Radiology. 1994;192(2):401–6. https://doi.org/10.1148/radiology.192.2.8029404.

    Article  CAS  PubMed  Google Scholar 

  22. Soyer P, Dufresne AC, Somveille E, Scherrer A. Hepatic cavernous hemangioma: appearance on T2-weighted fast spin-echo MR imaging with and without fat suppression. AJR Am J Roentgenol. 1997;168(2):461–5. https://doi.org/10.2214/ajr.168.2.9016227.

    Article  CAS  PubMed  Google Scholar 

  23. Choi BI, Han MC, Park JH, Kim SH, Han MH, Kim CW. Giant cavernous hemangioma of the liver: CT and MR imaging in 10 cases. AJR Am J Roentgenol. 1989;152(6):1221–6. https://doi.org/10.2214/ajr.152.6.1221.

    Article  CAS  PubMed  Google Scholar 

  24. International Working Party. Terminology of nodular hepatocellular lesions. Hepatology. 1995;22(3):983–93.

    Article  Google Scholar 

  25. Nguyen BN, Flejou JF, Terris B, Belghiti J, Degott C. Focal nodular hyperplasia of the liver: a comprehensive pathologic study of 305 lesions and recognition of new histologic forms. Am J Surg Pathol. 1999;23(12):1441–54.

    Article  CAS  Google Scholar 

  26. Shirkhoda A, Farah MC, Bernacki E, Madrazo B, Roberts J. Hepatic focal nodular hyperplasia: CT and sonographic spectrum. Abdom Imaging. 1994;19(1):34–8.

    Article  CAS  Google Scholar 

  27. Shamsi K, De Schepper A, Degryse H, Deckers F. Focal nodular hyperplasia of the liver: radiologic findings. Abdom Imaging. 1993;18(1):32–8.

    Article  CAS  Google Scholar 

  28. Mortele KJ, Praet M, Van Vlierberghe H, Kunnen M, Ros PR. CT and MR imaging findings in focal nodular hyperplasia of the liver: radiologic-pathologic correlation. AJR Am J Roentgenol. 2000;175(3):687–92. https://doi.org/10.2214/ajr.175.3.1750687.

    Article  CAS  PubMed  Google Scholar 

  29. Hussain SM, Terkivatan T, Zondervan PE, Lanjouw E, de Rave S, Ijzermans JN, et al. Focal nodular hyperplasia: findings at state-of-the-art MR imaging, US, CT, and pathologic analysis. Radiographics. 2004;24(1):3–17. ; discussion 8–9. https://doi.org/10.1148/rg.241035050.

    Article  PubMed  Google Scholar 

  30. Horton KM, Bluemke DA, Hruban RH, Soyer P, Fishman EK. CT and MR imaging of benign hepatic and biliary tumors. Radiographics. 1999;19(2):431–51. https://doi.org/10.1148/radiographics.19.2.g99mr04431.

    Article  CAS  PubMed  Google Scholar 

  31. Seale MK, Catalano OA, Saini S, Hahn PF, Sahani DV. Hepatobiliary-specific MR contrast agents: role in imaging the liver and biliary tree. Radiographics. 2009;29(6):1725–48. https://doi.org/10.1148/rg.296095515.

    Article  PubMed  Google Scholar 

  32. Mortele KJ, Praet M, Van Vlierberghe H, de Hemptinne B, Zou K, Ros PR. Focal nodular hyperplasia of the liver: detection and characterization with plain and dynamic-enhanced MRI. Abdom Imaging. 2002;27(6):700–7. https://doi.org/10.1007/s00261-001-0140-6.

    Article  CAS  PubMed  Google Scholar 

  33. Bioulac-Sage P, Rebouissou S, Thomas C, Blanc JF, Saric J, Sa Cunha A, et al. Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry. Hepatology. 2007;46(3):740–8. https://doi.org/10.1002/hep.21743.

    Article  CAS  PubMed  Google Scholar 

  34. Thomeer MG, ME EB, de Lussanet Q, Biermann K, Dwarkasing RS, de Man R, et al. Genotype-phenotype correlations in hepatocellular adenoma: an update of MRI findings. Diagn Interv Radiol. 2014;20(3):193–9. https://doi.org/10.5152/dir.2013.13315.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Bioulac-Sage P, Balabaud C, Zucman-Rossi J. Subtype classification of hepatocellular adenoma. Dig Surg. 2010;27(1):39–45. https://doi.org/10.1159/000268406.

    Article  CAS  PubMed  Google Scholar 

  36. Katabathina VS, Menias CO, Shanbhogue AK, Jagirdar J, Paspulati RM, Prasad SR. Genetics and imaging of hepatocellular adenomas: 2011 update. Radiographics. 2011;31(6):1529–43. https://doi.org/10.1148/rg.316115527.

    Article  PubMed  Google Scholar 

  37. Farges O, Dokmak S. Malignant transformation of liver adenoma: an analysis of the literature. Dig Surg. 2010;27(1):32–8. https://doi.org/10.1159/000268405.

    Article  PubMed  Google Scholar 

  38. Xu HX, Liu GJ, Lu MD, Xie XY, Xu ZF, Zheng YL, et al. Characterization of small focal liver lesions using real-time contrast-enhanced sonography: diagnostic performance analysis in 200 patients. J Ultrasound Med. 2006;25(3):349–61.

    Article  Google Scholar 

  39. Prasad SR, Wang H, Rosas H, Menias CO, Narra VR, Middleton WD, et al. Fat-containing lesions of the liver: radiologic-pathologic correlation. Radiographics. 2005;25(2):321–31. https://doi.org/10.1148/rg.252045083.

    Article  PubMed  Google Scholar 

  40. Agrawal S, Agarwal S, Arnason T, Saini S, Belghiti J. Management of hepatocellular adenoma: recent advances. Clin Gastroenterol Hepatol. 2015;13(7):1221–30. https://doi.org/10.1016/j.cgh.2014.05.023.

    Article  PubMed  Google Scholar 

  41. Laumonier H, Bioulac-Sage P, Laurent C, Zucman-Rossi J, Balabaud C, Trillaud H. Hepatocellular adenomas: magnetic resonance imaging features as a function of molecular pathological classification. Hepatology. 2008;48(3):808–18. https://doi.org/10.1002/hep.22417.

    Article  PubMed  Google Scholar 

  42. van Aalten SM, Thomeer MG, Terkivatan T, Dwarkasing RS, Verheij J, de Man RA, et al. Hepatocellular adenomas: correlation of MR imaging findings with pathologic subtype classification. Radiology. 2011;261(1):172–81. https://doi.org/10.1148/radiol.11110023.

    Article  PubMed  Google Scholar 

  43. Lewin M, Handra-Luca A, Arrive L, Wendum D, Paradis V, Bridel E, et al. Liver adenomatosis: classification of MR imaging features and comparison with pathologic findings. Radiology. 2006;241(2):433–40. https://doi.org/10.1148/radiol.2412051243.

    Article  PubMed  Google Scholar 

  44. Grazioli L, Federle MP, Brancatelli G, Ichikawa T, Olivetti L, Blachar A. Hepatic adenomas: imaging and pathologic findings. Radiographics. 2001;21(4):877–92. https://doi.org/10.1148/radiographics.21.4.g01jl04877; discussion 92–4.

    Article  CAS  PubMed  Google Scholar 

  45. Thompson MD, Monga SP. WNT/beta-catenin signaling in liver health and disease. Hepatology. 2007;45(5):1298–305. https://doi.org/10.1002/hep.21651.

    Article  CAS  PubMed  Google Scholar 

  46. Levy AD, Murakata LA, Abbott RM, Rohrmann CA Jr. From the archives of the AFIP. Benign tumors and tumorlike lesions of the gallbladder and extrahepatic bile ducts: radiologic-pathologic correlation. Armed Forces Institute of Pathology. Radiographics. 2002;22(2):387–413. https://doi.org/10.1148/radiographics.22.2.g02mr08387.

    Article  PubMed  Google Scholar 

  47. Lewin M, Mourra N, Honigman I, Flejou JF, Parc R, Arrive L, et al. Assessment of MRI and MRCP in diagnosis of biliary cystadenoma and cystadenocarcinoma. Eur Radiol. 2006;16(2):407–13. https://doi.org/10.1007/s00330-005-2822-x.

    Article  PubMed  Google Scholar 

  48. Mortele KJ, Ros PR. Cystic focal liver lesions in the adult: differential CT and MR imaging features. Radiographics. 2001;21(4):895–910. https://doi.org/10.1148/radiographics.21.4.g01jl16895.

    Article  CAS  PubMed  Google Scholar 

  49. Martinoli C, Cittadini G Jr, Rollandi GA, Conzi R. Case report: imaging of bile duct hamartomas. Clin Radiol. 1992;45(3):203–5.

    Article  CAS  Google Scholar 

  50. Wohlgemuth WA, Bottger J, Bohndorf K. MRI, CT, US and ERCP in the evaluation of bile duct hamartomas (von Meyenburg complex): a case report. Eur Radiol. 1998;8(9):1623–6. https://doi.org/10.1007/s003300050599.

    Article  CAS  PubMed  Google Scholar 

  51. Slone HW, Bennett WF, Bova JG. MR findings of multiple biliary hamartomas. AJR Am J Roentgenol. 1993;161(3):581–3. https://doi.org/10.2214/ajr.161.3.8352110.

    Article  CAS  PubMed  Google Scholar 

  52. Semelka RC, Hussain SM, Marcos HB, Woosley JT. Biliary hamartomas: solitary and multiple lesions shown on current MR techniques including gadolinium enhancement. J Magn Reson Imaging. 1999;10(2):196–201.

    Article  CAS  Google Scholar 

  53. Bosman FT, World Health Organization, International Agency for Research on Cancer. WHO classification of tumours of the digestive system, vol. 3. 4th ed. Lyon: International Agency for Research on Cancer; 2010.

    Google Scholar 

  54. Shamsi K, de Schepper AMA. Medical imaging of focal liver lesions : a clinico-radiologic approach. Amsterdam: Elsevier; 1994.

    Google Scholar 

  55. Robbins SL, Kumar V, Cotran RS. Robbins and cotran pathologic basis of disease. 8th ed. Philadelphia: Saunders/Elsevier; 2010.

    Google Scholar 

  56. Choi JY, Lee JM, Sirlin CB. CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part I. Development, growth, and spread: key pathologic and imaging aspects. Radiology. 2014;272(3):635–54. https://doi.org/10.1148/radiol.14132361.

    Article  PubMed  PubMed Central  Google Scholar 

  57. McEvoy SH, McCarthy CJ, Lavelle LP, Moran DE, Cantwell CP, Skehan SJ, et al. Hepatocellular carcinoma: illustrated guide to systematic radiologic diagnosis and staging according to guidelines of the American Association for the Study of Liver Diseases. Radiographics. 2013;33(6):1653–68. https://doi.org/10.1148/rg.336125104.

    Article  PubMed  Google Scholar 

  58. Digumarthy SR, Sahani DV, Saini S. MRI in detection of hepatocellular carcinoma (HCC). Cancer Imaging. 2005;5:20–4. https://doi.org/10.1102/1470-7330.2005.0005.

    Article  PubMed  PubMed Central  Google Scholar 

  59. Chou R, Cuevas C, Fu R, Devine B, Wasson N, Ginsburg A, et al. Imaging techniques for the diagnosis of hepatocellular carcinoma: a systematic review and meta-analysis. Ann Inter Med. 2015;162(10):697–711. https://doi.org/10.7326/M14-2509.

    Article  Google Scholar 

  60. Lau WY. Hepatocellular carcinoma. World Scientific Publication: Hackensack; 2008.

    Book  Google Scholar 

  61. Choi BI, Lee JM. Advancement in HCC imaging: diagnosis, staging and treatment efficacy assessments: imaging diagnosis and staging of hepatocellular carcinoma. J Hepatobiliary Pancreat Sci. 2010;17(4):369–73. https://doi.org/10.1007/s00534-009-0227-y.

    Article  PubMed  Google Scholar 

  62. Willatt JM, Hussain HK, Adusumilli S, Marrero JA. MR imaging of hepatocellular carcinoma in the cirrhotic liver: challenges and controversies. Radiology. 2008;247(2):311–30. https://doi.org/10.1148/radiol.2472061331.

    Article  PubMed  Google Scholar 

  63. Parente DB, Perez RM, Eiras-Araujo A, Oliveira Neto JA, Marchiori E, Constantino CP, et al. MR imaging of hypervascular lesions in the cirrhotic liver: a diagnostic dilemma. Radiographics. 2012;32(3):767–87. https://doi.org/10.1148/rg.323115131.

    Article  PubMed  Google Scholar 

  64. Ganeshan D, Szklaruk J, Kundra V, Kaseb A, Rashid A, Elsayes KM. Imaging features of fibrolamellar hepatocellular carcinoma. AJR Am J Roentgenol. 2014;202(3):544–52. https://doi.org/10.2214/AJR.13.11117.

    Article  PubMed  Google Scholar 

  65. Ichikawa T, Federle MP, Grazioli L, Madariaga J, Nalesnik M, Marsh W. Fibrolamellar hepatocellular carcinoma: imaging and pathologic findings in 31 recent cases. Radiology. 1999;213(2):352–61. https://doi.org/10.1148/radiology.213.2.r99nv31352.

    Article  CAS  PubMed  Google Scholar 

  66. Blachar A, Federle MP, Ferris JV, Lacomis JM, Waltz JS, Armfield DR, et al. Radiologists’ performance in the diagnosis of liver tumors with central scars by using specific CT criteria. Radiology. 2002;223(2):532–9. https://doi.org/10.1148/radiol.2232010801.

    Article  PubMed  Google Scholar 

  67. Smith MT, Blatt ER, Jedlicka P, Strain JD, Fenton LZ. Best cases from the AFIP: fibrolamellar hepatocellular carcinoma. Radiographics. 2008;28(2):609–13. https://doi.org/10.1148/rg.282075153.

    Article  PubMed  Google Scholar 

  68. Han JK, Choi BI, Kim AY, An SK, Lee JW, Kim TK, et al. Cholangiocarcinoma: pictorial essay of CT and cholangiographic findings. Radiographics. 2002;22(1):173–87. https://doi.org/10.1148/radiographics.22.1.g02ja15173.

    Article  PubMed  Google Scholar 

  69. Chung YE, Kim MJ, Park YN, Choi JY, Pyo JY, Kim YC, et al. Varying appearances of cholangiocarcinoma: radiologic-pathologic correlation. Radiographics. 2009;29(3):683–700. https://doi.org/10.1148/rg.293085729.

    Article  PubMed  Google Scholar 

  70. Lim JH. Cholangiocarcinoma: morphologic classification according to growth pattern and imaging findings. AJR Am J Roentgenol. 2003;181(3):819–27. https://doi.org/10.2214/ajr.181.3.1810819.

    Article  PubMed  Google Scholar 

  71. Vilgrain V. Staging cholangiocarcinoma by imaging studies. HPB. 2008;10(2):106–9. https://doi.org/10.1080/13651820801992617.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  72. Jung AY, Lee JM, Choi SH, Kim SH, Lee JY, Kim SW, et al. CT features of an intraductal polypoid mass: differentiation between hepatocellular carcinoma with bile duct tumor invasion and intraductal papillary cholangiocarcinoma. J Comput Assist Tomogr. 2006;30(2):173–81.

    Article  Google Scholar 

  73. Neitlich JD, Topazian M, Smith RC, Gupta A, Burrell MI, Rosenfield AT. Detection of choledocholithiasis: comparison of unenhanced helical CT and endoscopic retrograde cholangiopancreatography. Radiology. 1997;203(3):753–7. https://doi.org/10.1148/radiology.203.3.9169700.

    Article  CAS  PubMed  Google Scholar 

  74. Maetani Y, Itoh K, Watanabe C, Shibata T, Ametani F, Yamabe H, et al. MR imaging of intrahepatic cholangiocarcinoma with pathologic correlation. AJR Am J Roentgenol. 2001;176(6):1499–507. https://doi.org/10.2214/ajr.176.6.1761499.

    Article  CAS  PubMed  Google Scholar 

  75. Vanderveen KA, Hussain HK. Magnetic resonance imaging of cholangiocarcinoma. Cancer Imaging. 2004;4(2):104–15. https://doi.org/10.1102/1470-7330.2004.0018.

    Article  PubMed  PubMed Central  Google Scholar 

  76. Palacios E, Shannon M, Solomon C, Guzman M. Biliary cystadenoma: ultrasound, CT, and MRI. Gastrointest Radiol. 1990;15(4):313–6.

    Article  CAS  Google Scholar 

  77. Buetow PC, Midkiff RB. MR imaging of the liver. Primary malignant neoplasms in the adult. Magn Reson Imaging Clin N Am. 1997;5(2):289–318.

    CAS  PubMed  Google Scholar 

  78. Namasivayam S, Martin DR, Saini S. Imaging of liver metastases: MRI. Cancer Imaging. 2007;7:2–9. https://doi.org/10.1102/1470-7330.2007.0002.

    Article  PubMed  PubMed Central  Google Scholar 

  79. Kamel IR, Bluemke DA. MR imaging of liver tumors. Radiol Clin N Am. 2003;41(1):51–65.

    Article  Google Scholar 

  80. Sica GT, Ji H, Ros PR. CT and MR imaging of hepatic metastases. AJR Am J Roentgenol. 2000;174(3):691–8. https://doi.org/10.2214/ajr.174.3.1740691.

    Article  CAS  PubMed  Google Scholar 

  81. Wernecke K, Vassallo P, Bick U, Diederich S, Peters PE. The distinction between benign and malignant liver tumors on sonography: value of a hypoechoic halo. AJR Am J Roentgenol. 1992;159(5):1005–9. https://doi.org/10.2214/ajr.159.5.1329454.

    Article  CAS  PubMed  Google Scholar 

  82. Chen MY, Bechtold RE, Savage PD. Cystic changes in hepatic metastases from gastrointestinal stromal tumors (GISTs) treated with Gleevec (imatinib mesylate). AJR Am J Roentgenol. 2002;179(4):1059–62. https://doi.org/10.2214/ajr.179.4.1791059.

    Article  PubMed  Google Scholar 

  83. Lee SY, Chuang JH, Huang CB, Hsiao CC, Wan YL, Ng SH, et al. Congenital bilateral cystic neuroblastoma with liver metastases and massive intracystic haemorrhage. Br J Radiol. 1998;71(851):1205–7. https://doi.org/10.1259/bjr.71.851.10434918.

    Article  CAS  PubMed  Google Scholar 

  84. Kanematsu M, Kondo H, Goshima S, Kato H, Tsuge U, Hirose Y, et al. Imaging liver metastases: review and update. Eur J Radiol. 2006;58(2):217–28. https://doi.org/10.1016/j.ejrad.2005.11.041.

    Article  PubMed  Google Scholar 

  85. Bartolozzi C. Magnetic resonance imaging in liver disease : technical approach, diagnostic imaging of liver neoplasms, focus on a new superparamagnetic contrast agent. Stuttgart: George Thieme Verlag; 2003.

    Google Scholar 

  86. Muramatsu Y, Takayasu K, Moriyama N, Shima Y, Goto H, Ushio K, et al. Peripheral low-density area of hepatic tumors: CT-pathologic correlation. Radiology. 1986;160(1):49–52. https://doi.org/10.1148/radiology.160.1.3012632.

    Article  CAS  PubMed  Google Scholar 

  87. Semelka RC, Hussain SM, Marcos HB, Woosley JT. Perilesional enhancement of hepatic metastases: correlation between MR imaging and histopathologic findings-initial observations. Radiology. 2000;215(1):89–94. https://doi.org/10.1148/radiology.215.1.r00mr2989.

    Article  CAS  PubMed  Google Scholar 

  88. Saini S, Nelson RC. Technique for MR imaging of the liver. Radiology. 1995;197(3):575–7. https://doi.org/10.1148/radiology.197.3.7480718.

    Article  CAS  PubMed  Google Scholar 

  89. Silva AC, Evans JM, McCullough AE, Jatoi MA, Vargas HE, Hara AK. MR imaging of hypervascular liver masses: a review of current techniques. Radiographics. 2009;29(2):385–402. https://doi.org/10.1148/rg.292085123.

    Article  PubMed  Google Scholar 

  90. Kelekis NL, Semelka RC, Woosley JT. Malignant lesions of the liver with high signal intensity on T1-weighted MR images. J Magn Reson Imaging. 1996;6(2):291–4.

    Article  CAS  Google Scholar 

  91. Danet IM, Semelka RC, Leonardou P, Braga L, Vaidean G, Woosley JT, et al. Spectrum of MRI appearances of untreated metastases of the liver. AJR Am J Roentgenol. 2003;181(3):809–17. https://doi.org/10.2214/ajr.181.3.1810809.

    Article  PubMed  Google Scholar 

  92. Wittenberg J, Stark DD, Forman BH, Hahn PF, Saini S, Weissleder R, et al. Differentiation of hepatic metastases from hepatic hemangiomas and cysts by using MR imaging. AJR Am J Roentgenol. 1988;151(1):79–84. https://doi.org/10.2214/ajr.151.1.79.

    Article  CAS  PubMed  Google Scholar 

  93. Outwater E, Tomaszewski JE, Daly JM, Kressel HY. Hepatic colorectal metastases: correlation of MR imaging and pathologic appearance. Radiology. 1991;180(2):327–32. https://doi.org/10.1148/radiology.180.2.2068294.

    Article  CAS  PubMed  Google Scholar 

  94. Sica GT, Ji H, Ros PR. Computed tomography and magnetic resonance imaging of hepatic metastases. Clin Liver Dis. 2002;6(1):165–79, vii.

    Article  Google Scholar 

  95. Bressler EL, Alpern MB, Glazer GM, Francis IR, Ensminger WD. Hypervascular hepatic metastases: CT evaluation. Radiology. 1987;162(1 Pt 1):49–51. https://doi.org/10.1148/radiology.162.1.3024210.

    Article  CAS  PubMed  Google Scholar 

  96. Mahfouz AE, Hamm B, Wolf KJ. Peripheral washout: a sign of malignancy on dynamic gadolinium-enhanced MR images of focal liver lesions. Radiology. 1994;190(1):49–52. https://doi.org/10.1148/radiology.190.1.8259426.

    Article  CAS  PubMed  Google Scholar 

  97. Low RN. Contrast agents for MR imaging of the liver. J Magn Reson Imaging. 1997;7(1):56–67.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ihab R. Kamel .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Fouladi, D., Shao, N., Zarghampour, M., Pandey, A., Pandey, P., Kamel, I.R. (2018). Radiographic Assessment for Liver Tumors. In: Cardona, K., Maithel, S. (eds) Primary and Metastatic Liver Tumors. Springer, Cham. https://doi.org/10.1007/978-3-319-91977-5_2

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-91977-5_2

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-91976-8

  • Online ISBN: 978-3-319-91977-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics